4.6 Article

Network-Free Inference of Knockout Effects in Yeast

期刊

PLOS COMPUTATIONAL BIOLOGY
卷 6, 期 1, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pcbi.1000635

关键词

-

资金

  1. Israel Science Foundation [385/06]

向作者/读者索取更多资源

Perturbation experiments, in which a certain gene is knocked out and the expression levels of other genes are observed, constitute a fundamental step in uncovering the intricate wiring diagrams in the living cell and elucidating the causal roles of genes in signaling and regulation. Here we present a novel framework for analyzing large cohorts of gene knockout experiments and their genome-wide effects on expression levels. We devise clustering-like algorithms that identify groups of genes that behave similarly with respect to the knockout data, and utilize them to predict knockout effects and to annotate physical interactions between proteins as inhibiting or activating. Differing from previous approaches, our prediction approach does not depend on physical network information; the latter is used only for the annotation task. Consequently, it is both more efficient and of wider applicability than previous methods. We evaluate our approach using a large scale collection of gene knockout experiments in yeast, comparing it to the state-of-the-art SPINE algorithm. In cross validation tests, our algorithm exhibits superior prediction accuracy, while at the same time increasing the coverage by over 25-fold. Significant coverage gains are obtained also in the annotation of the physical network.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression

Georgina D. Barnabas, Joo Sang Lee, Tamar Shami, Michal Harel, Lir Beck, Michael Selitrennik, Livnat Jerby-Arnon, Neta Erez, Eytan Ruppin, Tamar Geiger

Summary: This study highlights the crucial role of IDH2 in triple-negative breast cancer (TNBC) and HER2, and demonstrates its oncogenic effects in cell proliferation, glycolysis, and other metabolic processes. PHGDH and PSAT1 are identified as synthetic dosage lethal (SDL) partners of IDH2, and their knockout shows the essentiality in IDH2-high cells. Clinical findings suggest that patients with IDH2-high/PHGDH-low tumors have longer survival, and PHGDH inhibitors show effectiveness in treating IDH2-high cells.

CANCER RESEARCH (2021)

Correction Genetics & Heredity

Mutation-selection balance and compensatory mechanisms in tumour evolution (vol 22, pg 251, 2021)

Erez Persi, Yuri I. Wolf, David Horn, Eytan Ruppin, Francesca Demichelis, Robert A. Gatenby, Robert J. Gillies, Eugene V. Koonin

NATURE REVIEWS GENETICS (2021)

Review Genetics & Heredity

Mutation-selection balance and compensatory mechanisms in tumour evolution

Erez Persi, Yuri Wolf, David Horn, Eytan Ruppin, Francesca Demichelis, Robert A. Gatenby, Robert J. Gillies, Eugene Koonin

Summary: Intratumour heterogeneity and phenotypic plasticity enabled by various somatic aberrations, epigenetic and metabolic adaptations, play a crucial role in helping cancers resist treatment and survive under environmental stress. Understanding the interplay between genetic aberrations, the microenvironment, and epigenetic and metabolic cellular states is essential for early detection, prevention, and development of efficient therapeutic strategies for cancer.

NATURE REVIEWS GENETICS (2021)

Article Multidisciplinary Sciences

Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity

Kuoyuan Cheng, Nishanth Ulhas Nair, Joo Sang Lee, Eytan Ruppin

Summary: This study investigates the role of synthetic lethality in cancer risk, finding that the extent of co-inactivation of cancer synthetic lethal (cSL) gene pairs in normal tissues is associated with lower and delayed cancer risk. The up-regulation of more cSL gene pairs in cells exposed to carcinogens and in premalignant stages suggests a potential role of synthetic lethality in tumorigenesis. Moreover, the tissue specificity of tumor suppressor genes is linked to the expression of their cSL partner genes in normal tissues.

SCIENCE ADVANCES (2021)

Article Multidisciplinary Sciences

Predicting tissue-specific gene expression from whole blood transcriptome

Mahashweta Basu, Kun Wang, Eytan Ruppin, Sridhar Hannenhalli

Summary: This study demonstrates that an individual's whole blood transcriptome can predict tissue-specific expression levels for around 60% of genes across various tissues, with particularly high accuracy in skeletal muscle. Predictions based on blood transcriptome are almost as effective as actual tissue expression in identifying disease states for six different complex disorders, surpassing the traditional blood transcriptome approach. The development of TEEBoT provides a valuable tool for further research in other medical conditions.

SCIENCE ADVANCES (2021)

Article Oncology

A Transcriptionally Distinct Subpopulation of Healthy Acinar Cells Exhibit Features of Pancreatic Progenitors and PDAC

Vishaka Gopalan, Arashdeep Singh, Farid Rashidi Mehrabadi, Li Wang, Eytan Ruppin, H. Efsun Arda, Sridhar Hannenhalli

Summary: This study identifies edge epithelial cell states with oncogenic transcriptional activity in human organs without oncogenic mutations, with a particular focus on pancreatic ductal adenocarcinoma (PDAC). It also highlights the increase in the fraction of acinar cells with age in the pancreas, as well as the significantly higher presence of AE-like cells in human pancreatitis samples.

CANCER RESEARCH (2021)

Article Biology

Identification of drugs associated with reduced severity of COVID-19-a case-control study in a large population

Ariel Israel, Alejandro A. Schaffer, Assi Cicurel, Kuoyuan Cheng, Sanju Sinha, Eyal Schiff, Ilan Feldhamer, Ameer Tal, Gil Lavie, Eytan Ruppin

Summary: This study aimed to investigate the impact of existing medications on the risk of severe COVID-19 hospitalization and found that several medications, including ubiquinone, ezetimibe, rosuvastatin, flecainide, and vitamin D, were associated with reduced risk of hospitalization. These findings suggest a promising protective effect that warrants further investigation in prospective studies.
Article Biochemistry & Molecular Biology

Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets

Kuoyuan Cheng, Laura Martin-Sancho, Lipika R. Pal, Yuan Pu, Laura Riva, Xin Yin, Sanju Sinha, Nishanth Ulhas Nair, Sumit K. Chanda, Eytan Ruppin

Summary: The study utilized genome-scale metabolic modeling to analyze host metabolism changes during SARS-CoV-2 infection, predicted anti-viral targets, validated these targets using drug and genetic screening data, and provided potential anti-SARS-CoV-2 targets supported by clinical data for future evaluation.

MOLECULAR SYSTEMS BIOLOGY (2021)

Article Oncology

Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti-PD-1 Therapy

Kun Wang, Sushant Patkar, Joo Sang Lee, E. Michael Gertz, Welles Robinson, Fiorella Schischlik, David R. Crawford, Alejandro A. Schaeffer, Eytan Ruppin

Summary: This study presents two new computational methods that deconvolve tumor gene expression profiles and predict response to immune checkpoint blockade therapy.

CANCER DISCOVERY (2022)

Article Medicine, General & Internal

Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study

Ariel Israel, Eugene Merzon, Alejandro A. Schaffer, Yotam Shenhar, Ilan Green, Avivit Golan-Cohen, Eytan Ruppin, Eli Magen, Shlomo Vinker

Summary: In this study, it was found that the risk of COVID-19 infection gradually increased in adults who received their second dose of the BNT162b2 mRNA vaccine after at least 90 days, based on electronic health records.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Immunology

Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection

Ariel Israel, Yotam Shenhar, Ilan Green, Eugene Merzon, Avivit Golan-Cohen, Alejandro A. Schaeffer, Eytan Ruppin, Shlomo Vinker, Eli Magen

Summary: This study demonstrates that individuals who received the Pfizer-BioNTech mRNA vaccine have higher initial levels of antibodies compared to patients who had been infected with the SARS-CoV-2 virus, but experience a much faster exponential decrease in antibody levels.

VACCINES (2022)

Article Oncology

Ubiquitin Ligases Siah1a/2 Control Alveolar Macrophage Functions to Limit Carcinogen-Induced Lung Adenocarcinoma

Marzia Scortegagna, Yuanning Du, Linda M. Bradley, Kun Wang, Alfredo Molinolo, Eytan Ruppin, Rabi Murad, Ze'ev A. Ronai

Summary: Cellular components, such as myeloid cells, in the tumor microenvironment have significant impact on the progression and treatment response of lung adenocarcinoma (LUAD). This study reveals that the ubiquitin ligases Siah1a/2 regulate the differentiation and activity of alveolar macrophages (AM), and their control of AMs influences carcinogen-induced LUAD. The findings indicate that Siah1a/2 in AMs act as gatekeepers of lung cancer development by controlling inflammatory signaling, differentiation, and profibrotic phenotypes.

CANCER RESEARCH (2023)

Review Oncology

Big data in basic and translational cancer research

Peng Jiang, Sanju Sinha, Kenneth Aldape, Sridhar Hannenhalli, Cenk Sahinalp, Eytan Ruppin

Summary: Historically, cancer research has focused on a few essential pathways and genes, but recent advances in high-throughput technologies have led to the rapid accumulation of large-scale cancer omics data. The analysis of this "big data" requires significant computational resources and has the potential to bring new insights to cancer research. The combination of big data, bioinformatics, and artificial intelligence has already made notable advances in our understanding of cancer biology and translational research. Future progress will require collaboration among data scientists, clinicians, biologists, and policymakers.

NATURE REVIEWS CANCER (2022)

Article Oncology

Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types

Neelam Sinha, Sanju Sinha, Cristina Valero, Alejandro A. Scha, Kenneth Aldape, Kevin Litch, Timothy A. Chan, Luc G. T. Morris, Eytan Ruppin

Summary: This study uncovers immune-related factors that may modulate the relationship between high tumor mutational burden and ICI response, which can help prioritize cancer types for clinical trials.

CANCER RESEARCH (2022)

Meeting Abstract Oncology

Epigenomic tumor evolution modeling with single-cell methylation data profiling.

Xuan C. Li, Yuelin Liu, Farid Rashidi, Salem Malikic, Stephen M. Mount, Eytan Ruppin, Kenneth Aldape, Cenk Sahinalp

CANCER RESEARCH (2021)

暂无数据